Anti-Thyroid Drugs Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Anti-Thyroid Drugs Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Anti-Thyroid Drugs Market:
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

According to The Business Research Company’s Anti-Thyroid Drugs Global Market Report 2024, The anti-thyroid drugs market size has grown steadily in recent years. It will grow from $2.4 billion in 2023 to $2.46 billion in 2024 at a compound annual growth rate (CAGR) of 2.5%.  The  growth in the historic period can be attributed to prevalence of thyroid disorders, advancements in drug development, healthcare infrastructure.

The anti-thyroid drugs market size is expected to see steady growth in the next few years. It will grow to $2.75 billion in 2028 at a compound annual growth rate (CAGR) of 2.8%.  The growth in the forecast period can be attributed to patient awareness and education, healthcare expenditure, patient demographics, global economic conditions. Major trends in the forecast period include thyroid surgery and radioactive iodine alternatives, patient-centric care, telemedicine and remote monitoring.

Graves’ disease is one of the direct causes of hyperthyroidism and the incidence of Graves’ disease increasing. According to National Library of Medicine, a US-based biomedical library operated by the United States federal government, in developed countries, Graves’ disease (GD) is the most common cause of hyperthyroidism. It is more common between the ages of 30 and 60, and women are 5–10 times more likely than men. Genetic predisposition accounts for 79% of the risk for GD, while environmental factors account for 21%. Owing to the rising number of Grave’s disease, people suffering from hyperthyroidism are also increasing. This results in the overall growth in the demand for anti-thyroid drugs thereby driving the market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3401&type=smp

The anti-thyroid drugs market covered in this report is segmented –
1) By Drug Type: Thionamides (Inhibition of hormone synthesis); Iodides (Inhibition of hormone release)
2) By Route of Administration: Oral; Intravenous; Other Route of Administration
3) By Distribution Channel: Wholesaler/Distributors; Retail Chain; Online Distribution; Other Distribution Channels

The anti-thyroid drugs market report table of contents includes:
1. Executive Summary

2. Anti-Thyroid Drugs Market Characteristics
3. Anti-Thyroid Drugs Market Trends And Strategies
4. Anti-Thyroid Drugs Market – Macro Economic Scenario
5. Global Anti-Thyroid Drugs Market Size and Growth
   .
   31. Global Anti-Thyroid Drugs Market Competitive Benchmarking
6. Global Anti-Thyroid Drugs Market Competitive Dashboard
7. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market
8. Anti-Thyroid Drugs Market Future Outlook and Potential Analysis
9. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model